首页 | 本学科首页   官方微博 | 高级检索  
     

小剂量阿糖胞苷和维甲酸治疗高危MDS25例疗效观察
引用本文:李新刚 夏玉彬. 小剂量阿糖胞苷和维甲酸治疗高危MDS25例疗效观察[J]. 四川肿瘤防治, 2000, 13(4): 240-241
作者姓名:李新刚 夏玉彬
作者单位:河南省安阳地区医院血液科!安阳,455000,河南省安阳地区医院血液科!安阳,455000,河南省安阳地区医院血液科!安阳,455000,河南省安阳地区医院血液科!安阳,455000,河南省安阳地区医院血液科!安阳,455000
摘    要:
目的:研究高危MDS的治疗方法,观察小剂量阿糖胞苷(LD-Ara-c)和全反式维甲酸(ATRA)诱导治疗高危MDS的疗效。方法:高危MDS25例,应用LD-Ara-c10-15mg/m^2,每12小时1次皮下注射,21天一疗程,间隔10天~15天重复;ATRA30~60mg/d,分3次口服。结果:完全缓解9例(36%),部分缓解4例(16%),4例进步,8例无效,总有效率52%;10例(40%)在

关 键 词:骨髓增生异常综合征 阿糖胞苷 维甲酸 剂量 疗效

ATRA and LD-Ara-c treatment for 25 cases withhigh risk myelodysplastic syndrome
LI Xin-gang,XIA Yu-bin,DING Xian-chao et al.Anyang District Hospital,Anyang. ATRA and LD-Ara-c treatment for 25 cases withhigh risk myelodysplastic syndrome[J]. Sichuan Journal of Cancer Control, 2000, 13(4): 240-241
Authors:LI Xin-gang  XIA Yu-bin  DING Xian-chao et al.Anyang District Hospital  Anyang
Affiliation:LI Xin-gang,XIA Yu-bin,DING Xian-chao et al.Anyang District Hospital,Anyang 455000
Abstract:
Objective:To observe the effects of all trans retinoic acid (ATRA) and LD Ara c induced therapy in high risk myelodysplastic syndrome (MDS);Methods:25 MDS patients were treated by LD Ara c and ATRA.Ara c 10 15 mg/m2 were given by hypodermic injection every 12 hours for 21 days,ATRA 30 60 mg/d tid per os.Results:9 cases had got complete remission(CR)(36%),4 cases partial remission (PR)(16%),4 cases improved,and 88 cases ineffective.10 cases turned into AML during treatment or after obtaining CR/PR.Conclusion:The results show that LD Ara c and ATRA induced therapy is an effective method in improving the patient prognosis.
Keywords:Myelodysplastic syndorme  LD Ara c  All trans retinal acid
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号